Gender, estrogen, and schizophrenia

Psychopharmacology Bulletin

Volumn 33, Issue 2, 1997, Pages 221-228

  Lindamer, Laurie A ^a,c   Lohr, James B ^a,b   Harris, M Jackuelyn ^a,b   Jeste, Dilip V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Dopamine; Estrogen; Gender; Schizophrenia

Indexed keywords

DOPAMINE; ESTRADIOL; ESTROGEN;

ARTICLE; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG EFFECT; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GENDER; HUMAN; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; AGE OF ONSET; AGED; ESTROGENS; FEMALE; HUMANS; MALE; MENSTRUAL CYCLE; MIDDLE AGED; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 0030873271     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC: The Association, 1987.
2. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: The Association, 1994.
3. Andia, AM; Zisook, S; Heaton, RK; Hesselink, J; Jernigan, T; Kuck, J; Moranville, J; and Braff, DL. Gender differences in schizophrenia. J. Nerv. Ment. Dis. 183:(8)522-528, 1995.
4. Andia, AM, and Zisook, S. Gender differences in schizophrenia: A literature review. Ann. Clin. Psychiatry 3:333-340, 1991.
5. Andreasen, NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa, 1981.
6. Andreasen, NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa, 1984.
7. Bedard, P; Boucher, R; Di Paolo, T; and Labrie, F. Biphasic effect of estradiol and domperidone on lingual dyskinesia in monkeys. Exp. Neurol. 82:(1)172-182, 1983.
8. Bedard, PJ; Di Paolo, T; Langelier, P; Poyet, P; and Labrie, F. Behavioural and biochemical evidence of an effect of estradiol on striatal dopamine receptors. In: Fuxe, K; Gustafsson, JA; and Wetterberg, L, eds. Steroid Hormone Regulation of the Brain. Oxford: Pergamon Press, 1981. pp. 331-339.
9. Bedard, PJ; Boucher, R; Daigle, M; and Di Paolo, T. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoneuroendocrinology 9:(4)375-379, 1984.
10. Broverman, DM; Vogel, W; Klaiber, EL; Majcher, D; Shea, D; and Paul, V. Changes in cognitive task performance across the menstrual cycle. J. Comp. Physiol. Psychol. 95:646-654, 1981.
11. Castle, DJ; Sham, PC; Wessely, S; and Murray, RM. The subtyping of schizophrenia in men and women: A latent class analysis. Psychol. Med. 24:41-51, 1994.
12. 3H]spiperone in the rat. Brain Res. 172:360-366, 1979.
13. Clopton, JK, and Gordon, JH. The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensitivity. Brain Res. 333:1-10, 1985.
14. Da Silva, L, and Johnstone, EC. A follow-up study of severe puerperal psychiatric illness. Br. J. Psychiatry 139:346-354, 1981.
15. Davies, A; McIvor, RJ; and Kumar, C. Impact of childbirth on a series of schizophrenic mothers: A comment on the possible influence of oestrogen on schizophrenia. Schizophr. Res. 16:25-31, 1995.
16. Davis, KL; Kahn, RS; Ko, G; and Davidson, M. Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiatry 148:1474-1486, 1991.
17. 3H] RU24213 binding in rat anterior pituitary gland and brain. Mol. Cell. Endocrinol. 16:99-112, 1979.
18. Di Paolo, T; Poyet, P; and Labrie, F. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur. J. Pharmacol. 73:105-106, 1981.
19. Di Paolo, T; Poyet, P; and Labrie, F. Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 6:377-382, 1982.
20. Dupont, A; Di Paolo, T; Gagne, B; and Barden, N. Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of overiectomized rats. Neurosci. Lett. 22:69-74, 1981.
21. Euvrard, C; Oberlander, C; and Boissier, JR. Antidopaminergic effect of estrogens at the striatal level. J. Pharmacol. Exp. Ther. 214:(1)179-185, 1979.
22. Folstein, MF; Folstein, SE; and McHugh, PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198, 1975.
23. Gattaz, WF; Vogel, P; Riecher-Rossler, A; and Soddu, G. influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol. Psychiatry 36:137-139, 1994.
24. Goldberg, TE; Gold, JM; Torrey, EF; and Weinberger, DR. Lack of sex differences in the neuropsychological performance of patients with schizophrenia. Am. J. Psychiatry 152:(6)883-888, 1995.
25. Goldstein, JM; Santangelo, SL; Simpson, JC; and Tsuang, MT. The role of gender in identifying subtypes of schizophrenia: A latent class analytic approach. Schizophr. Bull 16:(2)263-275, 1990.
26. Gordon, JH; Borison, RL; and Diamond, BI. Modulation of dopamine receptor sensitivity by estrogen. Biol. Psychiatry 15(3):389-396, 1980.
27. Gordon, JH, and Diamond, BI. Antagonism of dopamine supersensitivity by estrogen: Neurochemical studies in an animal model of tardive dyskinesia. Biol. Psychiatry 16:(4)365-371, 1981.
28. Gordon, JH, and Perry, KO. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity. Brain Res. Bull. 10:425-428, 1983.
29. Hafner, H; Behrens, S; De Vry, J; and Gattaz, WF. An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia. Psychiatry Res. 38:125-134, 1991.
30. Hafner, H; Riecher-Rossler, A; Maurer, K; Fatkenheuer, B; and Loffler, W. First onset and early symptomatology of schizophrenia: A chapter of epidemiological and neurobiological research into age and sex differences. Eur. Arch. Psychiatry Neurol. Sci. 242:109-118, 1992.
31. Hafner, H; Maurer, K; Loffler, W; and Riecher-Rossler, A. The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry 162:80-86, 1993.
32. Hallonquist, JD; Seeman, MV; Lang, M; and Rector, NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol. Psychiatry 33:207-209, 1993.
33. Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:278-296, 1967.
34. Harris, MJ; Heaton, SC; Lindamer, LA; Paulsen, JS; Bailey, A; Gladsjo, JA; McAdams, LA; Fell, RL; Zisook, S; Heaton, RK; and Jeste, DV. Gender and schizophrenia. In: Light, E, and Lebowitz, B, eds. Sex Hormones, Aging and Mental Disorders. Washington, DC: National Institute of Mental Health, submitted 1997.
35. Harris, MJ, and Jeste, DV. Late-onset schizophrenia: An overview. Schizophr. Bull. 14:39-55, 1988.
36. Honigfeld, G; Gillis, RD; and Klett, CJ. NOISE: Nurses observation scale for inpatient evaluation. In: Guy, W, ed. ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Pub. No. (ADM)76-338. Rockville, MD: National Institute of Mental Health, 1976.
37. Hruska, RE, and Silbergeld, EK. Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model. Science 208:1466-1468, 1980.
38. Jeste, DV; Neckers, LM; Wagner, RL; Wise, CD; Staub, RA; Rogol, A; Potkin, SG; Bridge, TP; and Wyatt, RJ. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia. J. Clin. Psychiatry 42:75-77, 1981.
39. Jeste, DV; Harris, MJ; Krull, A; Kuck, J; McAdams, LA; and Heaton, R. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am. J. Psychiatry 152:(5)722-730, 1995.
40. Kay, SR; Fiszbein, A; and Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13:2:261-276, 1987.
41. Kendell, RE; Chalmers, JC; and Platz, C. Epidemiology of puerperal psychoses. Br. J. Psychiatry 150:662-673, 1987.
42. Korhonen, S; Saarijarvi, S; and Aito, M. Successful estradiol treatment of psychotic symptoms in the premenstrual phase: A case report. Acta Psychiatr. Scand. 92:237-238, 1995.
43. Kraepelin, E. Psychiatrie ein Lehrbuch fur Studierende und Aertzte. Barth, Leipzig, 1909.
44. Kulkarni, J; de Castella, A; and Smith, D. Adjunctive estrogen treatment in women with schizophrenia. Schizophr. Res. 15:157, 1995.
45. Lewine, R. Sex differences in schizophrenia: Timing or subtype? Psychol. Bull. 90:432-444, 1981.
46. Lewine, RRJ; Walker, EF; Shurett, R; Caudle, J; and Haden, C. Sex differences in neuropsychological functioning among schizophrenic patients. Am. J. Psychiatry 153:(9)1178-1184, 1996.
47. Lindamer, LA, and Jeste, DV. Estrogen and psychosis: Is there an association. Clinical Advances in the Treatment of Psychiatric Disorders 10:6 (in press) 1997a.
48. Lindamer, LA; Lohr, JB; Harris, MJ; McAdams, LA; and Jeste, DV. Gender-related clinical differences in older patients with schizophrenia. J. Clin. Psychiatry, submitted, 1997b.
49. Maurer, K, and Hafner, H. Methodological aspects of onset assessment in schizophrenia. Schizophr. Res. 15:265-276, 1995.
50. McNeil, TF. A prospective study of postpartum psychoses in a high-risk group. Acta Psychiatr. Scand. 75:35-43, 1987.
51. McNiel, DE; Greenfield, TK; Attkisson, CC; and Binder, R. Factor structure of a brief symptom checklist for acute psychiatric inpatients. J. Clin. Psychol. 45:66-72, 1989.
52. Nausieda, PA; Koller, WC; Weiner, WJ; and Klawans, HL. Modification of postsynaptic dopaminergic sensitivity by female sex hormones. Life Sci. 25:521-526, 1979.
53. Overall, JE, and Gorham, DR. The Brief Psychiatric Rating Scale. Psychol. Rep. 10:799-812, 1962.
54. Riecher, A; Maurer, K; Loffler, W; Fatkenheuer, B; van der Heiden, W; Munk-Jorgenson, P; Stromgen, E; and Hafner, H. Gender differences in age at onset and course of schizophrenic disorders. In: Hafner, H, and Gattaz, WF, eds. Search for the Causes of Schizophrenia. Berlin Heidelberg: Springer-Verlag, 1990. pp. 14-33.
55. Riecher-Rossler, A; Hafner, H; Dutsch-Strobel, A; Oster, M; Stumbaum, M; vanGulick-Bailer, M; and Loffler, W. Further evidence for a specific role of estradiol in schizophrenia? Biol. Psychiatry 36:492-495, 1994a.
56. Riecher-Rossler, A; Hafner, H; Stumbalum, M; Maurer, K; and Schmidt, R. Can estradiol modulate schizophrenic symptomatology? Schizophr. Bull. 20:203-213, 1994b.
57. Riecher-Rossler, A, and Hafner, H. Schizophrenia and oestrogens - is there an association? Eur. Arch. Psychiatry Clin. Neurosci. 242:323-328, 1993.
58. Seeman, MV. Interaction of sex, age, and neuroleptic dose. Compr. Psychiatry 24(2): 125-128, 1983.
59. Seeman, MV, and Lang, M. The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 16:185-194, 1990.
60. Sherwin, BB, and Gelfand, MM. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendocrinology 10:(3)325-335, 1985.
61. Spitzer, RL; Williams, JBW; Gibbon, M; and First, MB. Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P, 4/1/88). New York: Biometrics Research Department, New York State Psychiatric Institute, 1988.
62. Vahia, NS; Doongaji, DR; and Jeste, DV. Psychological medicine. In: Vakil, RJ, ed. Textbook of Medicine. Bombay: Association of Physicians of India, 1973. pp. 1476-1498.
63. v. Zerssen, D, and Koeller, DM. Klinische Selbstbeurteilungs-Skalen (KSb-Si) aus dem München er Psychhiatrischen Information System (PSYCHIS München) Manuale (cited in Riechler-Rossler 1994). Weinheim: Beltz, 1976.
64. Van Hartesveldt, C, and Joyce, JN. Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10:1-14, 1986.
65. Wahl, OF, and Hunter, J. Are gender effects being neglected in schizophrenia research? Schizophr. Bull. 18:(2)313-317, 1992.
66. Wechsler, D. WAIS-R Manual. Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation, 1981.
67. Wieck, A; Kumar, R; Hirst, AD; Marks, MN; Campbell, IC; and Checkley, SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br. J. Med. 303:613-616, 1991.